Ethylene

Ethylene

SCHEMBL174250

C=C.C=C.F.F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL126503 1.00
Ethylene SCHEMBL1034291 1.00
Ethylene SCHEMBL22098 1.00
Ethylene SCHEMBL7719080 1.00
Ethylene SCHEMBL126504 1.00
Ethylene SCHEMBL10405444 1.00
Ethylene SCHEMBL23567319 1.00
Ethylene SCHEMBL2476362 1.00
Ethylene SCHEMBL10405443 1.00
Ethylene SCHEMBL3895135 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8957190-B2 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto JAPAN TOBACCO INC. (JP) 2015-02-17 US claimed
EP-2112168-B1 USE OF THERMOSTABLE BIOTIN-BINDING PROTEIN JAPAN TOBACCO INC (JP) 2014-10-01 EP claimed
US-20130309691-A1 USE OF HEAT-RESISTANT BIOTIN-BINDING PROTEIN, AND SOLID SUPPORT HAVING THE PROTEIN ATTACHED THERETO JAPAN TOBACCO INC. (JP) 2013-11-21 US claimed
US-20100330701-A1 USE OF HEAT-RESISTANT BIOTIN-BINDING PROTEIN, AND SOLID SUPPORT HAVING THE PROTEIN ATTACHED THERETO JAPAN TOBACCO INC. (JP) 2010-12-30 US claimed
EP-2112168-A1 USE OF THERMOSTABLE BIOTIN-BINDING PROTEIN AND SOLID SUPPORT HAVING THE PROTEIN BOUND THERETO Japan Tobacco Inc. (JP) 2009-10-28 EP claimed
US-10844109-B2 Method for producing erythrocyte proteins INSTITUT NATIONAL TRANSFUSION SANGUINE (FR) 2020-11-24 US disclosed
US-20190023765-A1 METHOD FOR PRODUCING ERYTHROCYTE PROTEINS INSTITUT NATIONAL TRANSFUSION SANGUINE (FR) 2019-01-24 US disclosed
EP-3362481-A1 METHOD FOR PRODUCING ERYTHROCYTE PROTEINS Institut National Transfusion Sanguine (FR) 2018-08-22 EP disclosed
EP-2894223-A1 Modified biotin-binding protein Japan Tobacco Inc (JP) 2015-07-15 EP disclosed
US-9034590-B2 Method for detecting substance in biological sample JAPAN TOBACCO INC. (JP) 2015-05-19 US disclosed
EP-2314681-B1 MODIFIED BIOTIN-BINDING PROTEIN JAPAN TOBACCO INC (JP) 2015-04-22 EP disclosed
US-8957190-B2 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto JAPAN TOBACCO INC. (JP) 2015-02-17 US disclosed
EP-2112168-A1 USE OF THERMOSTABLE BIOTIN-BINDING PROTEIN AND SOLID SUPPORT HAVING THE PROTEIN BOUND THERETO Japan Tobacco Inc. (JP) 2009-10-28 EP disclosed
EP-0914471-B1 METHOD FOR DISSOCIATING BIOTIN COMPLEXES SEQUENOM INC (US) 2002-04-03 EP disclosed
US-6303309-B1 DECOMPLEXING BY CONTACT WITH AMINE SEQUENOM, INC. 2001-10-16 US disclosed
US-6140053-A DETERMINING A SEQUENCE OF A NUCLEIC ACID SEQUENOM, INC. (US) 2000-10-31 US disclosed
US-6074823-A RAPID, ACCURATE, AND DIRECT METHOD BY USING MULTIPLE COPIES OF TARGET NUCLEIC ACID WITH AT LEAST ONE MASS-MODIFIED NUCLEOTIDE, CLEAVING WITH EXONUCLEASE INHIBITED BY MODIFIED NUCLEOTIDE, IDENTIFYING FRAGMENTS USING MASS SPECTROMETRY SEQUENOM, INC. (US) 2000-06-13 US disclosed
US-6022688-A RELEASING A BIOTIN COMPOUND:BIOTIN-BINDING COMPOUND COMPLEX; CONTACTING COMPLEX WITH AMMONIA EFFECTIVELY CAUSING RELEASE OF COMPLEX SEQUENOM, INC. (US) 2000-02-08 US disclosed
EP-0914471-A2 METHOD FOR DISSOCIATING BIOTIN COMPLEXES SEQUENOM, INC. (US) 1999-05-12 EP disclosed
WO-1997043617-A2 METHOD FOR DISSOCIATING BIOTIN COMPLEXES SEQUENOM, INC. (US) 1997-11-20 WO disclosed